2018
DOI: 10.1016/j.psc.2018.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Deep Brain Stimulation in Psychiatry

Abstract: Deep brain stimulation has preliminary evidence of clinical efficacy, but has been difficult to develop into a robust therapy, in part because its mechanisms are incompletely understood. We review evidence from movement and psychiatric disorder studies, with an emphasis on how deep brain stimulation changes brain networks. From this, we argue for a network-oriented approach to future deep brain stimulation studies. That network approach requires methods for identifying patients with specific circuit/network de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 83 publications
0
12
0
Order By: Relevance
“…DBS therapy requires fine tuning of individual patients’ stimulation parameters, altering the applied electric field to engage a target circuit 7 . A challenge in mental illness is that there is no objective biomarker of that engagement, and thus no rigorous definition of “effective dose” 8,9 . The brain’s response to electrical stimulation has been studied for decades, from simple preparations to complex modeling 7,10,11 .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…DBS therapy requires fine tuning of individual patients’ stimulation parameters, altering the applied electric field to engage a target circuit 7 . A challenge in mental illness is that there is no objective biomarker of that engagement, and thus no rigorous definition of “effective dose” 8,9 . The brain’s response to electrical stimulation has been studied for decades, from simple preparations to complex modeling 7,10,11 .…”
Section: Introductionmentioning
confidence: 99%
“…Despite those studies, the precise therapeutic mechanism of DBS’ high-frequency stimulation is a topic of frequent debate. Current theories focus around resetting of abnormal oscillatory activity, which may alter information transmission in distributed circuits 8,12 . This uncertainty suggests that some patients who did not respond in clinical trials likely did not receive an active dose of the study intervention.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In Parkinson’s disease, pathological beta band activity may represent an essential biomarker for adaptive stimulation (Moraud et al, 2018). However, biomarker identification in psychiatric disease states will prove to be more challenging due to clinical heterogeneity, and may be dependent on identifying commonalities among disease phenotypes (Bilge et al, 2018). The implantation of DBS electrodes allows for both acute (microelectrode) and chronic (macroelectrode) recordings to identify potential electrophysiological biomarkers in psychiatric disease states.…”
Section: Future Directionsmentioning
confidence: 99%
“…With the emergence of studies including adaptive model, and with the improvement of the quality of the pacemakers (expected to be fully and automatically programmable, compatible with biomarker variations, and flexible in stimulation type and pattern), a closed loop model could be considered in a next future in neurology 71. But concerning psychiatry, it remained more of a vision than a near-term guarantee 73. Indeed, the researchers first need to determine endophenotypes to identify candidate predictive algorithms for adjustments settings; which could be transferred to an automatic controller in the DBS system itself (Development of Adaptive Deep Brain Stimulation for OCD, NCT03457675).…”
Section: Perspectivesmentioning
confidence: 99%